Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine

Daniel J Isaacman1, Mark A Fletcher, Bernard Fritzell

  • 1Global Medical Affairs, Wyeth Pharmaceuticals, 500 Arcola Road, Collegeville, PA 19426, USA. ISAACMD@wyeth.com

Vaccine
|October 20, 2006
PubMed

Insights

Widespread use of Prevnar (pneumococcal conjugate vaccine; PCV7) indirectly protects unvaccinated individuals by reducing disease transmission. This finding supports the cost-effectiveness of vaccination programs for invasive pneumococcal disease (IPD).

Area of Science:

  • Public Health
  • Vaccinology
  • Epidemiology

Background:

  • Prevnar (pneumococcal conjugate vaccine; PCV7) targets invasive pneumococcal disease (IPD) caused by specific serotypes.
  • Indirect protection occurs when vaccination reduces pathogen transmission, benefiting unvaccinated populations.
  • Infants and young children are key reservoirs for vaccine-type pneumococcal bacteria.

Purpose of the Study:

  • To review published data on IPD incidence in unvaccinated individuals.
  • To assess the indirect protection conferred by universal PCV7 vaccination programs.
  • To inform cost-benefit analyses of vaccination strategies.

Main Methods:

  • Systematic review of published reports.
  • Analysis of IPD incidence data from 1998-2005.
  • Focus on non-immunised populations in countries with PCV7 programs.

Main Results:

  • Non-immunised individuals demonstrated a benefit from indirect protection.
  • Widespread PCV7 vaccination led to decreased transmission of vaccine serotypes.
  • This indirect effect enhances the economic justification for vaccination programs.

Conclusions:

  • Universal PCV7 vaccination provides significant indirect protection to unvaccinated individuals.
  • The findings support the value of PCV7 in public health interventions.
  • Ongoing surveillance is crucial for monitoring non-vaccine type IPD, especially in high-risk groups.

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Vaccinations01:51

Vaccinations

Overview
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...